Vaccines protect most people from serious illness, but the strength of that protection can vary considerably from one person to another. A new study led by Arizona State University helps us understand why.
A new study led by Arizona State University (U.S.A.) has identified biomarkers that, analyzed using artificial intelligence, could allow predicting which people will best respond to a vaccine even before they receive it.